Concepedia
Statistics
Publications
7
Citations
470
H-Index
Active since
2002
Affiliations
KU Leuven(Current)
Rega Institute for Medical Research
University of Southern California
Center for Cancer Research
National Institutes of Health
Valery Fikkert is an author at KU Leuven specializing in drug discovery, hiv, and medicine.
Top concepts
HivMedicinePharmacologyDrug DiscoveryVirologyImmunologyBiochemistryMedicinal ChemistryBiomolecular EngineeringGlycobiology
Publications per year
2002–2006
Development of Resistance against Diketo Derivatives of Human Immunodeficiency Virus Type 1 by Progressive Accumulation of Integrase Mutations
Valery Fikkert, Bénédicte Van Maele, Jo Vercammen et al. · Journal of Virology · 2003 · 98 citations · Full text
Resistance of Human Immunodeficiency Virus Type 1 to the High-Mannose Binding Agents Cyanovirin N and Concanavalin A
Myriam Witvrouw, Valery Fikkert, Anke Hantson et al. · Journal of Virology · 2005 · 95 citations · Full text
Immunology, Glycobiology, Hm Glycans +19
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site
Laith Q. Al‐Mawsawi, Valery Fikkert, Raveendra Dayam et al. · Proceedings of the National Academy of Sciences · 2006 · 93 citations · Full text
Drug Target, Molecular Biology, Chemical Biology +16
Multiple mutations in human immunodeficiency virus-1 integrase confer resistance to the clinical trial drug S-1360
Valery Fikkert, Anneleen Hombrouck, Barbara Van Remoortel et al. · AIDS · 2004 · 81 citations
Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives
Wim Pluymers, Godwin C. G. Pais, Bénédicte Van Maele et al. · Antimicrobial Agents and Chemotherapy · 2002 · 47 citations · Full text
1–5 of 7